Pages that link to "Q24647023"

The following pages link to Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats (Q24647023):

Displaying 42 items.

• Future pharmacological treatments for substance use disorders (Q22242633) ‎ (← links)
• The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice (Q24596842) ‎ (← links)
• The mGluR2 positive allosteric modulator BINA decreases cocaine self-administration and cue-induced cocaine-seeking and counteracts cocaine-induced enhancement of brain reward function in rats (Q24631402) ‎ (← links)
• The "stop" and "go" of nicotine dependence: role of GABA and glutamate (Q26824406) ‎ (← links)
• Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation (Q26853630) ‎ (← links)
• GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence (Q27026530) ‎ (← links)
• The GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats (Q27305120) ‎ (← links)
• GABAergic gene expression in postmortem hippocampus from alcoholics and cocaine addicts; corresponding findings in alcohol-naïve P and NP rats (Q28478892) ‎ (← links)
• Nicotine response genetics in the zebrafish. (Q30491214) ‎ (← links)
• Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice (Q30539539) ‎ (← links)
• Intracranial self-stimulation to evaluate abuse potential of drugs. (Q33845750) ‎ (← links)
• Discovery of a Negative Allosteric Modulator of GABAB Receptors (Q33889093) ‎ (← links)
• Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system (Q34012381) ‎ (← links)
• GABAB receptor-positive modulators: enhancement of GABAB receptor agonist effects in vivo (Q34214765) ‎ (← links)
• Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments. (Q34224871) ‎ (← links)
• Both GABA(B) receptor activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in rats (Q34696292) ‎ (← links)
• Repeated administration of the GABAB receptor positive modulator BHF177 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine seeking in rats (Q34770872) ‎ (← links)
• Activation of the GABA(B) Receptor Prevents Nicotine-Induced Locomotor Stimulation in Mice (Q35641953) ‎ (← links)
• Effects of the GABAB receptor-positive modulators CGP7930 and rac-BHFF in baclofen- and γ-hydroxybutyrate-discriminating pigeons (Q35913130) ‎ (← links)
• Positive allosteric modulation of the GABA(B) receptor by GS39783 attenuates the locomotor stimulant actions of ethanol and potentiates the induction of locomotor sensitization (Q36074885) ‎ (← links)
• Comparison of the effect of the GABAΒ receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats (Q36095127) ‎ (← links)
• Cocaine-induced reward enhancement measured with intracranial self-stimulation in rats bred for low versus high saccharin intake (Q36599317) ‎ (← links)
• Discriminative stimulus effects of the GABAB receptor-positive modulator rac-BHFF: comparison with GABAB receptor agonists and drugs of abuse (Q36642400) ‎ (← links)
• Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions (Q36727844) ‎ (← links)
• Mechanism-based medication development for the treatment of nicotine dependence. (Q37018610) ‎ (← links)
• Review. Neurobiology of nicotine dependence (Q37024161) ‎ (← links)
• Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation (Q37315470) ‎ (← links)
• Development of pharmacotherapies for drug addiction: a Rosetta stone approach (Q37383571) ‎ (← links)
• Effect of fendiline on the maintenance and expression of methamphetamine-induced conditioned place preference in Sprague-Dawley rats (Q37705299) ‎ (← links)
• GABAB receptor allosteric modulators exhibit pathway-dependent and species-selective activity (Q37724281) ‎ (← links)
• Novel GABA(B) receptor positive modulators: a patent survey (Q37774348) ‎ (← links)
• GABAB receptors in reward processes (Q37775215) ‎ (← links)
• Efficacy and tolerability of baclofen in substance use disorders: a systematic review (Q38115144) ‎ (← links)
• KK-92A, a novel GABAB receptor positive allosteric modulator, attenuates nicotine self-administration and cue-induced nicotine seeking in rats (Q38432098) ‎ (← links)
• An historical perspective on GABAergic drugs (Q39768840) ‎ (← links)
• Chemistry and pharmacology of GABAB receptor ligands (Q42959792) ‎ (← links)
• Association of a polymorphism in the NRXN3 gene with the degree of smoking in schizophrenia: a preliminary study (Q43297922) ‎ (← links)
• Anticonvulsant and behavioral effects of GABA(B) receptor positive modulator CGP7930 in immature rats (Q43470797) ‎ (← links)
• Operant, oral alcoholic beer self-administration by C57BL/6J mice: effect of BHF177, a positive allosteric modulator of GABA(B) receptors. (Q51804509) ‎ (← links)
• Effects of co-administration of the GABAB receptor agonist baclofen and a positive allosteric modulator of the GABAB receptor, CGP7930, on the development and expression of amphetamine-induced locomotor sensitization in rats. (Q54364129) ‎ (← links)
• Diversity of structure and function of GABAB receptors: a complexity of GABAB-mediated signaling (Q90438743) ‎ (← links)
• Effects of Chronic Inhalation of Electronic Cigarette Vapor Containing Nicotine on Neurotransmitters in the Frontal Cortex and Striatum of C57BL/6 Mice (Q92920980) ‎ (← links)